Namsa To Acquire European-Based Medanex Clinic To Expand Early-Stage Preclinical Research Capabilities
Namsa To Acquire European-Based Medanex Clinic To Expand Early-Stage Preclinical Research Capabilities
03/30/22, 12:31 PM
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its nearing acquisition of Medanex Clinic, a Belgium-based European preclinical research organization.
Company Info
Company info
NAMSA is a world-leading MedTech testing, clinical, and regulatory consulting firm dedicated to accelerating medical device product development. With a deep pool of testing, clinical, and regulatory experts, NAMSA helps medical device sponsors improve healthcare and is committed to enhancing stakeholder value through strategic outsourcing and comprehensive in-house services.